Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
Go back to Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination| (NASDAQ: CMND) | Delayed: 1.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.85 | 52 Week High | $ | |||
| Open | $1.85 | 52 Week Low | $ | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.85 | EPS | $ | |||
| Volume | 9,115 | |||||
| (NASDAQ: PLRZ) | Delayed: 10.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.75 | 52 Week High | $ | |||
| Open | $10.75 | 52 Week Low | $ | |||
| Day High | $10.75 | P/E | N/A | |||
| Day Low | $10.75 | EPS | $ | |||
| Volume | 2,002 | |||||
